Pathology News
Artificial intelligence-powered predictive analytics tools can improve hospital operations by optimizing capacity demands, alerting care teams of patients who may be at risk for adverse events and anticipating supply shortages, among other...
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of...
Two of Moderna’s founders, and one investor, are among 44 new billionaires on the Forbes 400 list this year At least three people with a stake in the coronavirus vaccine race have just made a list of the top 400 richest people in...
Top 5 Reasons WHY YOU SHOULD ADOPT DIGITAL PATHOLOGY INTO YOUR LABORATORY Thinking about going digital in your lab? Download this informative article that can help answer some of the most frequently asked questions about adopting digital...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...
Findings of multi-site study highlight potential of technology in real-world practice PHILADELPHIA – October 5, 2021 – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new...
